$113.13
Q4314 identifies Reeva, while Q4315 identifies Regenelink. Select the code matching the product documented as supplied and applied.
On this page
CMS RVU26D · Effective 2026-10-01
Q4315 Amniotic allograft Medicare reimbursement rates in Kentucky
Report Q4315 for Regenelink amniotic membrane allograft used with a primary wound-treatment procedure, with units supported by the amount applied. Compare Q4315 office and facility rates across CMS payment localities in Kentucky.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
What does Medicare pay for Q4315 in Kentucky?
Kentucky has 1 payment locality in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the payment area shown below, using the same CMS release.
Office / nonfacility
$113.13
1 of 1 localities have a supported rate.
Payment area: Kentucky
One mapped payment locality.
Facility setting
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Skin substitute products
About Q4315: Regenelink amniotic membrane allograft
Report Q4315 for Regenelink amniotic membrane allograft used with a primary wound-treatment procedure, with units supported by the amount applied.
Q4315 identifies the Regenelink amniotic membrane allograft supplied for wound treatment. The graft is placed over a prepared wound as a covering or adjunct to wound care. Wound-care clinicians, podiatrists, and surgeons may use amniotic membrane products in outpatient settings for wounds such as diabetic foot ulcers or venous leg ulcers; the specific product documented must be Regenelink for this code to apply.
Report Q4315 with the primary procedure for the graft application; CMS classifies it as an add-on code paid within that procedure’s global period. The record should identify the product, wound site, application procedure, and amount applied, with units reflecting the product’s per-square-centimeter billing basis. CMS classifies this code as technical-component-only, with interpretation covered by a separate code. The Q4315 line represents the product’s technical portion, not interpretation.
CMS billing rules for Q4315
- Global period
- Add-on code: billed only together with a primary procedure and paid within that procedure's global period.
- Professional and technical components
- Technical-component-only code: a separate code covers interpretation.
Where the value comes from
- Work RVU0.00 · 0%
- Practice expense (office) RVU3.81 · 100%
- Malpractice RVU0.00 · 0%
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Q4315 compared with similar codes
Office rates for Kentucky, from the same CMS release.
$113.13
Q4316 identifies Amchoplast rather than Regenelink. These product codes are not interchangeable based solely on both being amniotic membrane products.
$146.05
15271 reports the application procedure for qualifying grafts on trunk, arms, or legs; Q4315 identifies the Regenelink product supplied with a primary procedure.
Compare Q4315 by payment locality
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
1 of 1 payment localities
Kentucky →
Office / nonfacility
$113.13
Facility
Unavailable
Need rates for a whole code list?
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
How this local rate is calculated
Each RVU component is multiplied by its own geographic practice cost index (GPCI). The three adjusted components are added, then multiplied by the conversion factor. These are the inputs used for Q4315 in Kentucky.
PPRRVU2026_Oct_nonQPP.csv
18,402
- Code
- Q4315
- Physician work
- 0.00
- Practice expense
- 3.81
- Malpractice
- 0.00
GPCI2026.csv
55
- Locality
- Kentucky
- Physician work
- 1.000
- Practice expense
- 0.889
- Malpractice
- 0.915
| Component | RVU | Locality factor | Adjusted |
|---|---|---|---|
| Physician work | 0.00 | × 1.000 | 0.0000 |
| Practice expense | 3.81 | × 0.889 | 3.3871 |
| Malpractice | 0.00 | × 0.915 | 0.0000 |
| Total RVUs | 3.3871 | ||
| Conversion factor | × 33.4009 | ||
Office / nonfacility rate, Kentucky$113.13
Explore RVUs, geographic factors and the full formula
Office / nonfacility
| Component | RVU | Local GPCI |
|---|---|---|
| Work | 0 | 1 |
| Practice expense | 3.81 | 0.889 |
| Malpractice | 0 | 0.915 |
(0 × 1 + 3.81 × 0.889 + 0 × 0.915) × $33.4009 = $113.13
The office and facility calculations use their respective practice-expense RVUs. The facility amount here is the physician fee, not a separate hospital or facility bill.
Q4315 billing questions
When should Q4315 be selected instead of another amniotic membrane product code?
Use Q4315 when the product supplied and applied is Regenelink. Choose another product-specific code when the record identifies a different product; the general tissue type alone does not determine the code.
Can Q4315 be reported without a wound-application procedure?
No. CMS identifies Q4315 as an add-on code that must be billed with a primary procedure, and its payment falls within that procedure’s global period.
How should units for Q4315 be supported?
Document the wound site and the amount of Regenelink applied. Report units on the code’s per-square-centimeter basis.
Does Q4315 include interpretation?
No. CMS classifies Q4315 as technical-component-only and indicates that a separate code covers interpretation.
What documentation supports reporting Q4315?
The record should identify Regenelink by product name, describe the treated wound and application, and support the quantity reported. It should also show the primary procedure billed with the add-on code.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.
18,399Q4312,,"Acesso ac, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,400Q4313,,"Dermabind fm, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,401Q4314,,"Reeva, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,402Q4315,,Regenelink amniotic mem allo,A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,403Q4316,,"Amchoplast, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,404Q4317,,"Vitograft, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
18,405Q4318,,"E-graft, per sq cm",A,,0.00,3.81,,3.81,NA,0.00,3.81,3.81,3,ZZZ,0.00,0.00,0.00,0,0,0,0,0,9,,33.4009,09,0,99,0.00,0.00,0.00
5208102,IN,00,INDIANA,1.000,0.927,0.486
5305102,IA,00,IOWA,1.000,0.915,0.397
5405202,KS,00,KANSAS,1.000,0.904,0.504
5515102,KY,00,KENTUCKY,1.000,0.889,0.915
5607202,LA,01,NEW ORLEANS,1.000,0.941,1.136
5707202,LA,99,REST OF LOUISIANA,1.000,0.885,0.958
5814112,ME,03,SOUTHERN MAINE,1.000,0.991,0.631